An update from dorsaVi Limited ( ($AU:DVL) ) is now available.
dorsaVi Ltd has outlined plans for a new capital raise via a proposed issue of securities on the ASX, including up to 136,363,636 fully paid ordinary shares and 68,181,818 unlisted options exercisable at $0.045, expiring three years from the issue date. The placement, scheduled for 19 October 2026, is set to significantly expand the company’s capital base, potentially providing additional funding for its technology and commercial initiatives while diluting existing shareholders and signalling management’s intent to strengthen its financial position in a competitive medtech market.
More about dorsaVi Limited
dorsaVi Ltd is an ASX-listed company operating in the technology and medical devices sector, focused on developing and commercialising wearable sensor solutions and motion analysis systems. Its products are typically used in clinical, occupational health and safety, and sports settings, targeting customers seeking objective movement data and injury risk management tools.
Average Trading Volume: 890,345
Technical Sentiment Signal: Sell
Current Market Cap: A$30.88M
See more data about DVL stock on TipRanks’ Stock Analysis page.
